Volitionrx (VNRX) Cash from Financing Activities (2011 - 2025)

Volitionrx (VNRX) has 15 years of Cash from Financing Activities data on file, last reported at $6.2 million in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities rose 168.83% year-over-year to $6.2 million; the trailing twelve-month figure through Dec 2025 stood at $17.1 million (up 97.44% YoY), and the FY2025 full-year result was $17.1 million, up 97.44% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at $6.2 million, up from $1.6 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $20.2 million in Q1 2021 and bottomed at -$460198.0 in Q2 2022.
• The 5-year median for Cash from Financing Activities is $2.2 million (2021), against an average of $4.2 million.
• Peak annual rise in Cash from Financing Activities reached 13203.23% in 2022, while the deepest fall reached 191.81% in 2022.
• A 5-year view of Cash from Financing Activities shows it stood at $2.1 million in 2021, then tumbled by 55.85% to $925964.0 in 2022, then surged by 307.19% to $3.8 million in 2023, then tumbled by 39.27% to $2.3 million in 2024, then soared by 168.83% to $6.2 million in 2025.
• The last three Cash from Financing Activities figures came in at $6.2 million (Q4 2025), $1.6 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.

Peer Comparison